Abeona Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Abeona Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Abeona Therapeutics Inc
Rating: 2.08616675
Author: Trendlyne DVM scores

about

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene the...

4.82 0.24 (5.24%)

36.07% Fall from 52W High

766.6K

XNAS Volume

XNAS 02 Apr, 2026 5:30 PM (EDT)

Not Eligible

Mid Valuation

43.2 / 100

Technically Neutral

40.3 / 100

1Yr Price target upside is 306%

7 analysts

Abeona Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Abeona Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene the...

36.07% Fall from 52W High

SWOT Analysis

Abeona Therapeutics Inc Live Price Chart